NUTX vs. NMTC, MDAI, PLUR, THTX, NRXP, ACXP, DARE, ENLV, FEMY, and EVGN
Should you be buying Nutex Health stock or one of its competitors? The main competitors of Nutex Health include NeuroOne Medical Technologies (NMTC), Spectral AI (MDAI), Pluri (PLUR), Theratechnologies (THTX), NRx Pharmaceuticals (NRXP), Acurx Pharmaceuticals (ACXP), Daré Bioscience (DARE), Enlivex Therapeutics (ENLV), Femasys (FEMY), and Evogene (EVGN). These companies are all part of the "medical" sector.
NeuroOne Medical Technologies (NASDAQ:NMTC) and Nutex Health (NASDAQ:NUTX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, community ranking, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.
NeuroOne Medical Technologies has higher earnings, but lower revenue than Nutex Health. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.
NeuroOne Medical Technologies presently has a consensus target price of $2.20, indicating a potential upside of 92.98%. Nutex Health has a consensus target price of $15.00, indicating a potential upside of 2,218.39%. Given NeuroOne Medical Technologies' higher probable upside, analysts clearly believe Nutex Health is more favorable than NeuroOne Medical Technologies.
In the previous week, Nutex Health had 4 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 5 mentions for Nutex Health and 1 mentions for NeuroOne Medical Technologies. Nutex Health's average media sentiment score of 0.00 equaled NeuroOne Medical Technologies'average media sentiment score.
NeuroOne Medical Technologies has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.29, indicating that its stock price is 71% less volatile than the S&P 500.
NeuroOne Medical Technologies received 57 more outperform votes than Nutex Health when rated by MarketBeat users. However, 100.00% of users gave Nutex Health an outperform vote while only 71.59% of users gave NeuroOne Medical Technologies an outperform vote.
Nutex Health has a net margin of -18.49% compared to Nutex Health's net margin of -478.41%. NeuroOne Medical Technologies' return on equity of -45.58% beat Nutex Health's return on equity.
16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 7.5% of NeuroOne Medical Technologies shares are owned by company insiders. Comparatively, 48.5% of Nutex Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Nutex Health beats NeuroOne Medical Technologies on 9 of the 15 factors compared between the two stocks.
Get Nutex Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for NUTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NUTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nutex Health Competitors List
Related Companies and Tools
